Related references
Note: Only part of the references are listed.Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
J. Schreiber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-a and ribavirin
Y. Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus
Vincent Pedergnana et al.
PLOS ONE (2012)
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
Emma C. Thomson et al.
GUT (2011)
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype
Edmondo Falleti et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
The role of genetic markers in hepatitis C virus therapy: a major step for individualized care
John G. McHutchison
LIVER INTERNATIONAL (2011)
Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
Jeanette J. McCarthy et al.
GASTROENTEROLOGY (2010)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Interleukin-28B Genetic Variants and Hepatitis Virus Infection by Different Viral Genotypes
Marco Antonio Montes-Cano et al.
HEPATOLOGY (2010)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidemiology of hepatitis virus B and C
Margarita Dehesa-Violante et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
JM Micallef et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
HJ Alter et al.
SEMINARS IN LIVER DISEASE (2000)
Share Paper
